David Margolis

David currently serves as the CMO of Brii Biosciences, a clinical stage biotechnology company. He is a highly experienced infectious diseases and internal medicine physician with over 15 years of experience in pharmaceutical strategy, research and development, and executive leadership. David has worked on multiple complex development programs from preclinical studies through to approval and launch, including impactful product launches in HIV and COVID, with a particular focus on long-acting treatment modalities. David's career has been committed to bringing value to patients, while exhibiting strong and innovative leadership, leveraging internal and external collaborative partnerships across private, governmental and non-governmental organizations.